Search Results - "Pitzenberger, S M"

Refine Results
  1. 1

    High Fatty Acid Content in Rabbit Serum Is Responsible for the Differentiation of Osteoblasts Into Adipocyte‐like Cells by Diascro, Dominic D., Vogel, Robert L., Johnson, Timothy E., Witherup, Keith M., Pitzenberger, Steven M., Rutledge, Su Jane, Prescott, David J., Rodan, Gideon A., Schmidt, Azriel

    Published in Journal of bone and mineral research (01-01-1998)
    “…Osteoblasts and adipocytes originate from common mesenchymal precursors. With aging, there is a decrease in osteoprogenitor cells that parallels an increase of…”
    Get full text
    Journal Article
  2. 2

    In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase by Vickers, S, Duncan, C A, Vyas, K P, Kari, P H, Arison, B, Prakash, S R, Ramjit, H G, Pitzenberger, S M, Stokker, G, Duggan, D E

    Published in Drug metabolism and disposition (01-07-1990)
    “…Simvastatin (SV), an analog of lovastatin, is the lactone form of 1', 2', 6', 7', 8', 8a'-hexahydro-3,5-dihydroxy-2', 6'-dimethyl-8' (2",…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Characterization of a solid state reaction product from a lyophilized formulation of a cyclic heptapeptide. A novel example of an excipient-induced oxidation by DUBOST, D. C, KAUFMAN, M. J, ZIMMERMAN, J. A, BOGUSKY, M. J, CODDINGTON, A. B, PITZENBERGER, S. M

    Published in Pharmaceutical research (01-12-1996)
    “…To elucidate the structure of a degradation product arising from a lyophilized formulation of a cyclic heptapeptide, and to provide a mechanism to account for…”
    Get full text
    Journal Article
  5. 5

    Antibacterial Activity of Lonchocarpol A by Salvatore, Michael J, King, Aurora B, Graham, Amy C, Onishi, H. Russell, Bartizal, Kenneth F, Abruzzo, George K, Gill, Charles J, Ramjit, Harri G, Pitzenberger, Steven M, Witherup, Keith M

    “…Lonchocarpol A, a flavanone, demonstrates in vitro inhibitory activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant…”
    Get full text
    Journal Article
  6. 6

    Hepatic metabolism of spironolactone. Production of 3-hydroxy-thiomethyl metabolites by Los, L E, Pitzenberger, S M, Ramjit, H G, Coddington, A B, Colby, H D

    Published in Drug metabolism and disposition (01-11-1994)
    “…Spironolactone (SP) is used clinically as a renal aldosterone antagonist and as an antiandrogen. It is known that the drug is extensively metabolized and that…”
    Get more information
    Journal Article
  7. 7

    Metabolism of L-689,502 by rat liver slices to potent HIV-1 protease inhibitors by Balani, S K, Pitzenberger, S M, Schwartz, M S, Ramjit, H G, Thompson, W J

    Published in Drug metabolism and disposition (01-02-1995)
    “…L-689,502, N-[2(R)-hydroxy-1(S)-indanyl]-5(S)-(1,1-dimethylethoxy- carbonyl-amino)-4(S)-hydroxy-6-phenyl-2(R)-(4-[2(R)-(4-morpholinyl)…”
    Get more information
    Journal Article
  8. 8

    Physiological disposition and metabolism of L-365,260, a potent antagonist of brain cholecystokinin receptor, in laboratory animals by Chen, I W, Dorley, J M, Ramjit, H G, Pitzenberger, S M, Lin, J H

    Published in Drug metabolism and disposition (01-05-1992)
    “…L-365,260 [3R(+)-N-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4- benzodiazepine-3-yl)-N'-(3-methylphenylurea)], a potent nonpeptide antagonist of the CCKB…”
    Get more information
    Journal Article
  9. 9

    NMR studies of novel inhibitors bound to farnesyl‐protein transferase by Koblan, Kenneth S., Mosser, Scott D., Omer, Charles A., Christopher Culberson, J., Jane Desolms, S., Giuliani, Elizabeth A., Pitzenberger, Steven M., Bogusky, Michael J.

    Published in Protein science (01-04-1995)
    “…Farnesyl‐protein transferase (FPTase) catalyzes the posttranslational farnesylation of the cysteine residue located in the carboxyl‐terminal tetrapeptide of…”
    Get full text
    Journal Article
  10. 10

    Proton NMR assignments and secondary structure of the snake venom protein echistatin by Chen, Yuan, Pitzenberger, Steven M, Garsky, Victor M, Lumma, Patricia K, Sanyal, Gautam, Baum, Jean

    Published in Biochemistry (Easton) (17-12-1991)
    “…The snake venom protein echistatin is a potent inhibitor of platelet aggregation. The inhibitory properties of echistatin have been attributed to the…”
    Get full text
    Journal Article
  11. 11

    Metabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slices by Balani, S K, Pitzenberger, S M, Kauffman, L R, Arison, B H, Ramjit, H G, Goldman, M E, O'Brien, J A, King, J D, Hoffman, J M, Rooney, C S

    Published in Drug metabolism and disposition (01-11-1992)
    “…L-696,229 is a potent and specific inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase and is currently undergoing clinical…”
    Get more information
    Journal Article
  12. 12

    Biotransformation of lovastatin. I. Structure elucidation of in vitro and in vivo metabolites in the rat and mouse by Vyas, K P, Kari, P H, Pitzenberger, S M, Halpin, R A, Ramjit, H G, Arison, B, Murphy, J S, Hoffman, W F, Schwartz, M S, Ulm, E H

    Published in Drug metabolism and disposition (01-03-1990)
    “…Structures of in vitro microsomal and in vivo metabolites of lovastatin, a new cholesterol-lowering drug, were elucidated with the combined application of…”
    Get more information
    Journal Article
  13. 13

    In vivo and in vitro metabolism studies on a class III antiarrhythmic agent by Vickers, S, Duncan, C A, Kari, P H, Homnick, C F, Elliott, J M, Pitzenberger, S M, Hichens, M, Vyas, K P

    Published in Drug metabolism and disposition (01-05-1993)
    “…The metabolism of L-691,121 (I), a class III antiarrhythmic agent, was studied in vivo in rats and dogs and in vitro by using liver S9 or slices from these…”
    Get more information
    Journal Article
  14. 14

    Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor by Balani, S K, Goldman, M E, Kauffman, L R, Varga, S L, O'Brien, J A, Smith, S J, Olah, T V, Ramjit, H G, Schorn, T W, Pitzenberger, S M

    Published in Drug metabolism and disposition (01-07-1993)
    “…Rhesus monkeys were dosed orally with 10 mg/kg 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005), a nonnucleoside human immunodeficiency virus type 1…”
    Get more information
    Journal Article
  15. 15

    Metabolism of antiparkinson agent dopazinol by rat liver microsomes by Vyas, K P, Kari, P H, Ramjit, H G, Pitzenberger, S M, Hichens, M

    Published in Drug metabolism and disposition (01-11-1990)
    “…Metabolism of dopazinol (DZ) by liver microsomes from control and phenobarbital- and 3-methylcholanthrene-treated rats has been investigated. Liver microsomes…”
    Get more information
    Journal Article
  16. 16

    NMR and molecular modeling characterization of RGD containing peptides by Bogusky, M J, Naylor, A M, Pitzenberger, S M, Nutt, R F, Brady, S F, Colton, C D, Sisko, J T, Anderson, P S, Veber, D F

    “…The tripeptide sequence arginine-glycine-aspartic acid (RGD) has been shown to be the key recognition segment in numerous cell adhesion proteins. The solution…”
    Get more information
    Journal Article
  17. 17

    Disposition and metabolism of sodium 4-[(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl)sulfonyl]-gamma -oxobenzenebutanoate in rats and dogs by Tocco, D J, deLuna, F A, Duncan, A E, Ramjit, H G, Pitzenberger, S M, Hsieh, J Y

    Published in Drug metabolism and disposition (01-09-1988)
    “…The disposition of sodium 4-[(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl)sulfonyl]-gamma-o xo benzenebutanoate (L-648,051) was determined in rats and dogs…”
    Get more information
    Journal Article
  18. 18

    Conformation of a novel tetrapeptide inhibitor NH2-d-Trp-d-Met-Phe(pCl)-Gla-NH2 bound to farnesyl-protein transferase by Bogusky, M.J., Pitzenberger, S.M., Garsky, V.M., Culberson, J.C., Koblan, K.S., Wallace, A., Pessi, A.

    Published in The journal of peptide research (01-07-1999)
    “…: Farnesyl‐protein transferase (FPTase) catalyzes the post‐translational farnesylation of the cysteine residue located in the C‐terminal tetrapeptide of the…”
    Get full text
    Journal Article
  19. 19

    The solution conformation of Ac-Pen-Arg-Gly-Asp-Cys-OH, a potent fibrinogen receptor antagonist by Bogusky, M J, Naylor, A M, Mertzman, M E, Pitzenberger, S M, Nutt, R F, Brady, S F, Colton, C D, Veber, D F

    Published in Biopolymers (01-08-1993)
    “…The solution conformation of Ac-Pen-Arg-Gly-Asp-Cys-OH, a potent fibrinogen receptor antagonist, was characterized in DMSO-d6 by the combination of nmr and…”
    Get more information
    Journal Article
  20. 20

    Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans by Balani, S K, Kauffman, L R, Arison, B H, Olah, T V, Goldman, M E, Varga, S L, O'Brien, J A, Ramjit, H G, Rooney, C S, Hoffman, J M

    Published in Drug metabolism and disposition (01-03-1994)
    “…Healthy subjects were administered single oral doses of 800 mg or 400 mg 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-o ne (L-696,229), a…”
    Get more information
    Journal Article